Medlive Technology (HKG:2192) recorded a 5.9% rise in attributable profit in the first half of 2025 to 155.3 million yuan from 146.7 million yuan in the year-ago period, a Monday Hong Kong bourse filing said.

The online physician platform's earnings per share were 0.2098 yuan in the half year, up from 0.1984 yuan in the corresponding period of the last year.

Revenue in the six months rose 28% to 312 million yuan from 243.4 million yuan a year prior, mainly due to a higher revenue from its precision marketing and corporate services segment.

The firm declared an interim dividend of 0.1166 yuan per ordinary share, payable on or around Sept. 25 to shareholders of record on Sept. 11.